Logo image
Alexander Disease: A Novel Mutation in GFAP Leading to Epilepsia Partialis Continua
Journal article   Peer reviewed

Alexander Disease: A Novel Mutation in GFAP Leading to Epilepsia Partialis Continua

Daniel J Bonthius and Bahri Karacay
Journal of child neurology, Vol.31(7), pp.869-872
06/2016
DOI: 10.1177/0883073815624762
PMCID: PMC4865433
PMID: 26719496

View Online

Abstract

Alexander disease is a genetically induced leukodystrophy, due to dominant mutations in the glial fibrillary acidic protein (GFAP ) gene, causing dysfunction of astrocytes. We have identified a novel GFAP mutation, associated with a novel phenotype for Alexander disease. A boy with global developmental delay and hypertonia was found to have a leukodystrophy. Genetic analysis revealed a heterozygous point mutation in exon 6 of the GFAP gene. The guanine-to-adenine change causes substitution of the normal glutamic acid codon (GAG) with a mutant lysine codon (AAG) at position 312 (E312 K mutation). At the age of 4 years, the child developed epilepsia partialis continua, consisting of unabating motor seizures involving the unilateral perioral muscles. Epilepsia partialis continua has not previously been reported in association with Alexander disease. Whether and how the E312 K mutation produces pathologic changes and clinical signs that are unique from other Alexander disease-inducing mutations in GFAP remain to be determined.
Glial Fibrillary Acidic Protein - genetics Alexander Disease - complications Brain - diagnostic imaging Humans Child, Preschool Male Epilepsia Partialis Continua - genetics Phenotype Alexander Disease - diagnostic imaging Alexander Disease - physiopathology Mutation Alexander Disease - genetics Epilepsia Partialis Continua - physiopathology Epilepsia Partialis Continua - etiology Epilepsia Partialis Continua - diagnostic imaging

Details

Logo image